This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddy, S. V. Articles by Roodman, G. D. Search for Related Content PubMed PubMed Citation Articles by Reddy, S. V. Articles by Roodman, G. D.

Osteoclasts Formed by Measles Virus-Infected Osteoclast Precursors from hCD46 Transgenic Mice Express Characteristics of Pagetic Osteoclasts¹

Department of Medicine/Hematology, University of Texas Health Science Center (S.V.R., N.K., G.D.R.), San Antonio, Texas 78229; Department of Molecular/Cellular Physiology, University of Cincinnati (C.M.), Cincinnati, Ohio 45221; University of California at Irvine (D.F., G.L.), Orange, California 92868; Cancer Therapy and Research Center (B.A.K.), San Antonio, Texas 78229; Department of Human Genetics, Virginia Commonwealth University (J.J.W.), Richmond, Virginia 23298; VA Medical Center (G.D.R.), San Antonio, Texas 78284

Address all correspondence and requests for reprints to: G. David Roodman, M.D., Ph.D., Research/Hematology (151), Audie Murphy VA Hospital, 7400 Merton Minter Boulevard, San Antonio, Texas 78284. E-mail: roodman{at}uthscsa.edu

Pagetic osteoclasts (OCLs) are abnormal in size and contain paramyxoviral-like nuclear inclusions that cross-react with antibodies to measles virus (MV). However, the role that MV infection plays in Paget’s disease is unknown, because no animal model of Paget’s disease is available. Therefore, we targeted a cellular MV receptor, human CD46 (hCD46), to cells in the OCL lineage in transgenic mice using the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. In vitro infection of OCL precursors from hCD46 transgenic mice with MV significantly increased OCL formation in bone marrow cultures. The numbers of TRAP-positive mononuclear cells and CFU-GM, the earliest identifiable OCL precursor, were also significantly increased. MV-infected OCLs formed from hCD46 marrow were increased in size, contained markedly increased numbers of nuclei, and had increased bone-resorbing capacity per OCL compared with OCLs formed from marrow of nontransgenic littermates. Furthermore, IL-6 and 24-hydroxylase messenger RNA expression levels were increased in MV-infected hCD46 transgenic mouse bone marrow cultures. Treatment of MV-infected hCD46 marrow cultures with a neutralizing antibody to IL-6 blocked the increased OCL formation seen in these cultures. These data demonstrate that MV infection of OCL precursors results in OCLs that have many features of pagetic OCLs, that the enhanced OCL formation is in part mediated by increased IL-6 expression induced by MV infection, and suggest that the hCD46 transgenic mouse may be a useful model for examining the effects of MV infection on OCL formation in vivo.

This article has been cited by other articles:

				B. G. Matthews, M. A. Afzal, P. D. Minor, U. Bava, K. E. Callon, R. P. Pitto, T. Cundy, J. Cornish, I. R. Reid, and D. Naot Failure to Detect Measles Virus Ribonucleic Acid in Bone Cells from Patients with Paget's Disease J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1398 - 1401. [Abstract] [Full Text] [PDF]

				S. Ishizuka, N. Kurihara, S. V. Reddy, J. Cornish, T. Cundy, and G. D. Roodman (23S)-25-Dehydro-1{alpha}-Hydroxyvitamin D3-26,23-Lactone, a Vitamin D Receptor Antagonist that Inhibits Osteoclast Formation and Bone Resorption in Bone Marrow Cultures from Patients with Paget's Disease Endocrinology, April 1, 2005; 146(4): 2023 - 2030. [Abstract] [Full Text] [PDF]

				R. Bouillon, R. F. Klein, Y. Jiang, M. Petit, E. Seeman, P. Ducy, A. A. Reszka, D. Bikle, E. Schipani, G. J. Strewler, et al. Meeting Report from the 26th Annual Meeting of the American Society for Bone and Mineral Research: October 1-5, 2004 in Seattle, Washington, USA IBMS BoneKEy, November 1, 2004; 1(11): 6 - 50. [Full Text] [PDF]